During the past decade, Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi" #1 collaborator was "Center for Bioequivalence Studies and Clinical Research" with 3 trials as a collaborator, "Merck Pvt. Ltd, Pakistan" with 3 trials as a collaborator, "Center for Bioequivalence Studies and Clinical Research (CBSCR), HEJ Research Institute of chemistry, University of Karachi" with 2 trials as a collaborator, "SAMI Pharmaceutical, Karachi Pakistan" with 2 trials as a collaborator and "Center for bioequivalence studies and Clinical Research (CBSCR), ICCBS, University of Karachi" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi" are "Bioequivalence" (4 trials), "Bioequivalence Study" (4 trials), "Healthy" (3 trials), "Healthy Individuals" (2 trials) and "Healthy Volunteers" (2 trials). Many other conditions were trialed in "Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi" in a lesser frequency.

Most popular intervention types in "Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi" are "Drug" (13 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anplag (Ticagrelor 90 mg)" (1 trials), "Brilinta (Ticagrelor 90 mg)" (1 trials), "Clopid® 75 mg Tablet" (1 trials), "Control Group" (1 trials) and "Dexlansoprazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi" are 8 trials for "Male" genders, 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi, 9 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".